MULTIPARAMETRIC TUMOR-MARKER ANALYSES (CA 19-9, CEA, UROKINASE-TYPE ANTIGEN) IN PLASMA OF PATIENTS WITH COLORECTAL-CANCER OR CROHNS-DISEASE

被引：0
|
作者：
HUBER, K
SEDLMAYER, A
KIRCHHEIMER, JC
RIMPFL, T
BINDER, BR
机构：
[1] VIENNA UNIV, DEPT CLIN EXPTL PHYSIOL, A-1090 VIENNA, AUSTRIA
[2] VIENNA UNIV, DEPT CARDIOL, A-1090 VIENNA, AUSTRIA
[3] VIENNA UNIV, DEPT GASTROENTEROL 2, A-1090 VIENNA, AUSTRIA
来源：
BLUT | 1988年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [41] The predictive value of preoperative levels of CEA and CA 19-9 in colorectal cancer patients receiving adjuvant therapy
    Arie, Van Dalen
    Behbehani, A.
    Mathew, A.
    Farghaly, M.
    Stieber, P.
    Hofman, D.
    Nagel, D.
    Lau-Werner, U.
    Holubec, L.
    Topolcan, O.
    Finek, J.
    Cerna, M.
    Visokai, V.
    Lipska, L.
    TUMOR BIOLOGY, 2006, 27 : 20 - 20
  • [42] COMPARISON OF A NEW TUMOR-MARKER CA-242 WITH CA-19-9, CA-50 AND CARCINOEMBRYONIC ANTIGEN (CEA) IN DIGESTIVE-TRACT DISEASES
    KUUSELA, P
    HAGLUND, C
    ROBERTS, PJ
    BRITISH JOURNAL OF CANCER, 1991, 63 (04) : 636 - 640
  • [43] Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy
    Michl, M.
    Koch, J.
    Laubender, R. P.
    Modest, D. P.
    Giessen, C.
    Schulz, Ch.
    Heinemann, V.
    TUMOR BIOLOGY, 2014, 35 (10) : 10121 - 10127
  • [44] Methylated Reprimo in Cell-Free DNA (RPRM) in Comparison With CEA and CA 19-9 As a Tumor Marker in Gastric Cancer
    Corvalan, Alejandro H.
    Garrido, Marcelo
    Maturana, Mara J.
    Corsi, Oscar
    Ledermann, Gerardo
    GASTROENTEROLOGY, 2015, 148 (04) : S568 - S568
  • [45] USEFULNESS OF SERUM TUMOR MARKERS CEA, CA 19-9 AND CA 72-4 IN PATIENTS WITH COLORECTAL CANCER AND BENIGN COLORECTAL DISEASES. A RETROSPECTIVE MULTICENTRIC STUDY
    Lumachi, F.
    Basso, S. M. M.
    Marzano, B.
    Milan, Elise E.
    Galella, A.
    Chiara, Bruno G.
    ANNALS OF ONCOLOGY, 2010, 21 : 119 - 119
  • [46] EPITHELIAL TUMOR MARKERS (CA 125, CA 19-9 AND CEA) TRENDS IN PATIENTS UNDERGOING TREATMENT FOR INVASIVE BLADDER CANCER
    Bazargani, Soroush T.
    Shah, Swar
    Ahmadi, Hamed
    Schuckman, Anne
    Cai, Jie
    Miranda, Gus
    Dorff, Tanya
    Sadeghi, Sarmad
    Quinn, David
    Djaladat, Hooman
    Daneshmand, Siamak
    JOURNAL OF UROLOGY, 2015, 193 (04): : E483 - E484
  • [47] VALUE OF SERUM LEVELS OF CARCINOEMBRYONIC ANTIGEN, CEA, AND GASTROINTESTINAL CANCER ANTIGEN, GICA OR CA 19-9, FOR PREOPERATIVE STAGING AND POSTOPERATIVE MONITORING OF PATIENTS WITH COLORECTAL-CARCINOMA
    SZYMENDERA, JJ
    NOWACKI, MP
    KOZLOWICZGUDZINSKA, I
    KOWALSKA, M
    DISEASES OF THE COLON & RECTUM, 1985, 28 (12) : 895 - 899
  • [48] DIFFERENTIAL-DIAGNOSIS OF PANCREATIC DISEASES USE OF TUMOR-MARKER (CA 19-9,CEA,POA800,AFP)DETERMINATIONS IN PANCREATIC JUICES AND SERA
    SCHMIEGEL, WH
    EBERL, W
    KREIKER, C
    ARNDT, R
    CLASSEN, M
    GRETEN, H
    JESSEN, K
    KALTHOFF, H
    KLAPDOR, R
    SOEHENDRA, N
    THIELE, HG
    GASTROENTEROLOGY, 1984, 86 (05) : 1236 - 1236
  • [49] Novel tumor marker index using carcinoembryonic antigen and carbohydrate antigen 19-9 is a significant prognostic factor for resectable colorectal cancer
    Teppei Kamada
    Hironori Ohdaira
    Junji Takahashi
    Takashi Aida
    Keigo Nakashima
    Eisaku Ito
    Taigo Hata
    Masashi Yoshida
    Ken Eto
    Yutaka Suzuki
    Scientific Reports, 14
  • [50] Novel tumor marker index using carcinoembryonic antigen and carbohydrate antigen 19-9 is a significant prognostic factor for resectable colorectal cancer
    Kamada, Teppei
    Ohdaira, Hironori
    Takahashi, Junji
    Aida, Takashi
    Nakashima, Keigo
    Ito, Eisaku
    Hata, Taigo
    Yoshida, Masashi
    Eto, Ken
    Suzuki, Yutaka
    SCIENTIFIC REPORTS, 2024, 14 (01)
12345